SCHEMBL25175693

SCHEMBL25175693

COC(=O)c1cc(Br)cnc1NCCc1ccncc1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDR P35968 1/20 0.49
PGK1 P00558 1/20 0.43
MKNK1 Q9BUB5 2/20 0.41
ALDH1A1 P00352 5/20 0.41
F2 P00734 1/20 0.41
MAPT P10636 3/20 0.40
OPRK1 P41145 2/20 0.40
MEN1 O00255 2/20 0.40
KMT2A Q03164 2/20 0.40
HSD17B10 Q99714 1/20 0.40
HTT P42858 3/20 0.39
NPSR1 Q6W5P4 2/20 0.39
TDP1 Q9NUW8 2/20 0.39
CYP1A2 P05177 1/20 0.39
CYP3A4 P08684 1/20 0.39
CYP2D6 P10635 1/20 0.39
CYP2C9 P11712 1/20 0.39
CYP2C19 P33261 1/20 0.39
USP2 O75604 1/20 0.39
MAPK10 P53779 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3449466 0.80 ALDH1A1 (0.44) KDRALDH1A1OPRK1
SCHEMBL3345812 0.80 PIM1 (0.43) KDRALDH1A1MAPTOPRK1KMT2A
SCHEMBL3344583 0.77 OPRK1 (0.42) OPRK1
SCHEMBL12942164 0.75 MEN1 (0.47) ALDH1A1MAPTMEN1KMT2AHSD17B10
SCHEMBL3344339 0.73 OPRK1 (0.48) OPRK1
SCHEMBL29856041 0.73 OPRK1 (0.48) OPRK1
SCHEMBL444374 0.73 KDR (0.73) KDRALDH1A1MAPTMEN1KMT2A
SCHEMBL4930698 0.72 CSNK2A2 (0.41) ALDH1A1MAPTMEN1KMT2AHSD17B10
SCHEMBL28597704 0.72 OPRK1 (0.47) OPRK1
SCHEMBL3344759 0.71 RXFP1 (0.52) ALDH1A1OPRK1MEN1KMT2AHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023081730-A1 4-HYDROXY-2-OXO-1,2-DIHYDRO-1,8-NAPHTHYRIDINE-3-CARBOXAMIDE DERIVATIVES AS CANNABINOID CB2 RECEPTOR MODULATORS FOR THE TREATMENT OF CANCER TEON THERAPEUTICS, INC. (US) 2023-05-11 WO disclosed
WO-2023081730-A1 4-HYDROXY-2-OXO-1,2-DIHYDRO-1,8-NAPHTHYRIDINE-3-CARBOXAMIDE DERIVATIVES AS CANNABINOID CB2 RECEPTOR MODULATORS FOR THE TREATMENT OF CANCER TEON THERAPEUTICS, INC. (US) 2023-05-11 WO disclosed